| scholarly article | Q13442814 |
| P50 | author | Steffen Massberg | Q91105776 |
| P2093 | author name string | Ildiko Konrad | |
| Bernhard Nieswandt | |||
| Sabine Grüner | |||
| Valerie Schulte | |||
| Ulrich Heinzmann | |||
| Meinrad Gawaz | |||
| Dietlind Zohlnhöfer | |||
| P2860 | cites work | Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain | Q24308747 |
| Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor | Q24317407 | ||
| A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion | Q24621493 | ||
| Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily | Q28144674 | ||
| Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRgamma chain | Q28145083 | ||
| The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors | Q28145360 | ||
| Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation | Q28187729 | ||
| Lateral clustering of platelet GP Ib-IX complexes leads to up-regulation of the adhesive function of integrin alpha IIbbeta 3 | Q28216733 | ||
| Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen | Q28364081 | ||
| Evidence for two distinct epitopes within collagen for activation of murine platelets | Q31470306 | ||
| Alboaggregin A activates platelets by a mechanism involving glycoprotein VI as well as glycoprotein Ib. | Q31835076 | ||
| Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies | Q33331313 | ||
| Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. | Q33334252 | ||
| Collagen synthesis in atherosclerosis: too much and not enough | Q33643458 | ||
| Increased platelet deposition on atherosclerotic coronary arteries | Q34125013 | ||
| Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice | Q35829683 | ||
| Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice | Q36376147 | ||
| Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field | Q36407260 | ||
| Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions | Q37377651 | ||
| The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion | Q40766523 | ||
| Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. | Q45967882 | ||
| Platelet-endothelial cell interactions during ischemia/reperfusion: the role of P-selectin | Q47869831 | ||
| Alboluxin, a snake C-type lectin from Trimeresurus albolabris venom is a potent platelet agonist acting via GPIb and GPVI. | Q50225888 | ||
| Vitronectin inhibits the thrombotic response to arterial injury in mice. | Q54459609 | ||
| Integrin α2-Deficient Mice Develop Normally, Are Fertile, but Display Partially Defective Platelet Interaction with Collagen | Q57339936 | ||
| The role of ITAM- and ITIM-coupled receptors in platelet activation by collagen | Q63408039 | ||
| Platelet interaction with collagen fibrils in flowing blood. I. Reaction of human platelets with alpha chymotrypsin-digested subendothelium | Q67020885 | ||
| Platelet adhesion, release and aggregation in flowing blood: effects of surface properties and platelet function | Q67859296 | ||
| Accelerated rates of collagen synthesis in atherosclerotic arteries quantified in vivo | Q69439409 | ||
| Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen | Q69615135 | ||
| Mouse model of arterial injury | Q70489057 | ||
| Platelet adhesion | Q72003010 | ||
| Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo | Q73205671 | ||
| Mechanisms initiating platelet thrombus formation | Q73447586 | ||
| Platelet collagen receptors | Q74314917 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 41-49 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo | |
| P478 | volume | 197 |
| Q33379144 | A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex |
| Q90292249 | AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation |
| Q79086335 | Activated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cells |
| Q42741745 | Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents |
| Q22001540 | Aegyptin displays high-affinity for the von Willebrand factor binding site (RGQOGVMGF) in collagen and inhibits carotid thrombus formation in vivo |
| Q34033785 | Aegyptin, a novel mosquito salivary gland protein, specifically binds to collagen and prevents its interaction with platelet glycoprotein VI, integrin alpha2beta1, and von Willebrand factor |
| Q37526189 | Alteration of platelet GPVI signaling in ST-elevation myocardial infarction patients demonstrated by a combination of proteomic, biochemical, and functional approaches. |
| Q54488259 | An acquired defect associated with abnormal signaling of the platelet collagen receptor glycoprotein VI. |
| Q27304270 | Anti-Inflammatory and Anti-Thrombotic Effects of the Fungal Metabolite Galiellalactone in Apolipoprotein E-Deficient Mice |
| Q35550212 | Antiplatelet therapy: in search of the 'magic bullet'. |
| Q46790254 | Antithrombotic effect of the type III collagen-related octapeptide (KOGEOGPK) in the mouse. |
| Q37953778 | Arterial thrombosis--insidious, unpredictable and deadly |
| Q37897474 | Arterial thrombus formation in cardiovascular disease |
| Q38867733 | Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke |
| Q35849237 | Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPIb-dependent thrombus formation in vivo |
| Q64890368 | Btk inhibitors in atherosclerosis. |
| Q34318501 | CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo. |
| Q40783418 | CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice. |
| Q52600001 | Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions. |
| Q40087226 | Cofactor-independent human antiphospholipid antibodies induce venous thrombosis in mice |
| Q37801001 | Combating innate inflammation: a new paradigm for acute treatment of stroke? |
| Q41516753 | Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke |
| Q56363256 | Connexins and Pannexins in Vascular Function and Disease |
| Q40143775 | Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. |
| Q83363884 | Critical role of ADP interaction with P2Y12 receptor in the maintenance of alpha(IIb)beta3 activation: association with Rap1B activation |
| Q24646366 | Defective thrombus formation in mice lacking coagulation factor XII |
| Q42355573 | Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice |
| Q48283354 | Doxepin inhibits GPVI-dependent platelet Ca2+ signaling and collagen-dependent thrombus formation |
| Q35102293 | Dual-specificity phosphatase 3 deficiency or inhibition limits platelet activation and arterial thrombosis |
| Q36907577 | Dynamic and structural formation of a thrombus: the inciting event of arterial ischemic stroke |
| Q55468635 | Dysfunctional platelet membrane receptors: from humans to mice. |
| Q39592493 | EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall |
| Q38138876 | Emerging paradigms in arterial thrombosis |
| Q38117739 | Encryption and decryption of tissue factor. |
| Q37215693 | Endothelium-platelet interactions in inflammatory lung disease |
| Q42435363 | Estradiol accelerates endothelial healing through the retrograde commitment of uninjured endothelium. |
| Q30479254 | Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation |
| Q44904868 | Facilitating roles of murine platelet glycoprotein Ib and alphaIIbbeta3 in phosphatidylserine exposure during vWF-collagen-induced thrombus formation |
| Q36091308 | Fibrin activates GPVI in human and mouse platelets |
| Q34391705 | Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1. |
| Q28513888 | G13 is an essential mediator of platelet activation in hemostasis and thrombosis |
| Q44941572 | GPIb potentiates GPVI-induced responses in human platelets. |
| Q82211770 | GPVI and the not so eager cleaver |
| Q34674600 | Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists |
| Q90480558 | Glycoprotein VI in securing vascular integrity in inflamed vessels |
| Q24669536 | Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo |
| Q37272111 | Gremlin-1 is an inhibitor of macrophage migration inhibitory factor and attenuates atherosclerotic plaque growth in ApoE-/- Mice |
| Q38109969 | Harnessing the platelet signaling network to produce an optimal hemostatic response. |
| Q51001918 | Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature. |
| Q24304178 | IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation |
| Q38969861 | Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies |
| Q50554991 | Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin. |
| Q34215849 | In vivo evidence for platelet-induced physiological angiogenesis by a COX driven mechanism |
| Q47678335 | Increased platelet reactivity as measured by plasma glycoprotein VI in gout |
| Q50584072 | Inhibition of platelet GPIb alpha and promotion of melanoma metastasis. |
| Q42917596 | Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. |
| Q37902388 | Ischaemic stroke: a thrombo-inflammatory disease? |
| Q89563788 | LMU Munich: platelet inhibition novel aspects on platelet inhibition and function |
| Q28396616 | Leucocyte/endothelium interactions and microvessel permeability: coupled or uncoupled? |
| Q44917835 | Leukocyte-platelet aggregate adhesion and vascular permeability in intact microvessels: role of activated endothelial cells. |
| Q59281484 | Ligand Binding Rapidly Induces Disulfide-dependent Dimerization of Glycoprotein VI on the Platelet Plasma Membrane |
| Q37679719 | Limitations of current therapies to prevent thrombosis: a need for novel strategies |
| Q39416821 | Mechanical circulatory support is associated with loss of platelet receptors glycoprotein Ibα and glycoprotein VI. |
| Q28070313 | Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models |
| Q40361537 | Molecular imaging of vulnerable atherosclerotic plaques |
| Q35894194 | Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. |
| Q30372166 | Multimodal optoacoustic and multiphoton microscopy of human carotid atheroma. |
| Q26865345 | Next-generation antithrombotics in ischemic stroke: preclinical perspective on 'bleeding-free antithrombosis' |
| Q35882052 | Oral phenotype and scoring of vascular Ehlers-Danlos syndrome: a case-control study |
| Q91219173 | Pathogen interactions with endothelial cells and the induction of innate and adaptive immunity |
| Q35671956 | Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy. |
| Q35064907 | Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators |
| Q59341017 | Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients: A Systematic Review |
| Q37127000 | Platelet IκB kinase-β deficiency increases mouse arterial neointima formation via delayed glycoprotein Ibα shedding |
| Q37903934 | Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke |
| Q46070845 | Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro |
| Q36877378 | Platelet integrins and immunoreceptors |
| Q37486621 | Platelet interactions as therapeutic targets for prevention of atherothrombosis |
| Q37071700 | Platelet receptor redox regulation |
| Q37807924 | Platelet receptor signaling in thrombus formation |
| Q34086864 | Platelet recruitment to the inflamed glomerulus occurs via an alphaIIbbeta3/GPVI-dependent pathway. |
| Q33385900 | Platelet-associated IgAs and impaired GPVI responses in platelets lacking WIP. |
| Q92556952 | Platelets and Immune Responses During Thromboinflammation |
| Q38382518 | Platelets and the complement cascade in atherosclerosis |
| Q33387350 | Platelets contribute to postnatal occlusion of the ductus arteriosus |
| Q36230859 | Platelets in atherothrombosis: lessons from mouse models |
| Q36328825 | Platelets in inflammation and atherogenesis. |
| Q37035357 | Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells. |
| Q36238074 | Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo |
| Q39248498 | Platelets: much more than bricks in a breached wall. |
| Q33926055 | Polymorphisms in the platelet-specific collagen receptor GP6 are associated with risk of nonfatal myocardial infarction in Caucasians. |
| Q33861557 | Preoperative platelet response to collagen is associated with myocardial injury after off-pump coronary bypass graft in patients taking aspirin. |
| Q41975370 | Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation |
| Q33389665 | Proteolysis of platelet receptors in humans and other species |
| Q59281355 | Proteolytic processing of platelet receptors |
| Q27332468 | Quantification of the Blood Platelet Reactivity in the ADP-Induced Model of Non-Lethal Pulmonary Thromboembolism in Mice with the Use of Laser Doppler Flowmetry |
| Q46428451 | Rac1 is essential for phospholipase C-gamma2 activation in platelets |
| Q37196226 | Radionuclide imaging: a molecular key to the atherosclerotic plaque |
| Q42950062 | Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. |
| Q90245412 | Red blood cell-derived semaphorin 7A promotes thrombo-inflammation in myocardial ischemia-reperfusion injury through platelet GPIb |
| Q30539510 | Red blood cells mediate the onset of thrombosis in the ferric chloride murine model. |
| Q41880869 | Redundancy and interaction of thrombin- and collagen-mediated platelet activation in tail bleeding and carotid thrombosis in mice |
| Q88842600 | Regulation of Platelet Activation and Coagulation and Its Role in Vascular Injury and Arterial Thrombosis |
| Q35925623 | Resolving the multifaceted mechanisms of the ferric chloride thrombosis model using an interdisciplinary microfluidic approach. |
| Q37333850 | RhoG protein regulates platelet granule secretion and thrombus formation in mice. |
| Q47094364 | Rivaroxaban attenuates thrombosis by targeting the NF-κB signaling pathway in a rat model of deep venous thrombus |
| Q37511097 | Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice |
| Q34802412 | SLAP/SLAP2 prevent excessive platelet (hem)ITAM signaling in thrombosis and ischemic stroke in mice |
| Q30481898 | Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation |
| Q34245348 | Shaping the platelet response to vascular injury |
| Q38589520 | Spatiotemporal regulation of coagulation and platelet activation during the hemostatic response in vivo |
| Q90511412 | Start a fire, kill the bug: The role of platelets in inflammation and infection |
| Q33410728 | Structural and interaction analysis of glycoprotein VI-binding peptide selected from a phage display library |
| Q48697081 | Structural basis for the platelet-collagen interaction: the smallest motif within collagen that recognizes and activates platelet Glycoprotein VI contains two glycine-proline-hydroxyproline triplets. |
| Q33869531 | Sustained reperfusion after blockade of glycoprotein-receptor-Ib in focal cerebral ischemia: an MRI study at 17.6 Tesla |
| Q41775798 | Synthesis of huaicarbon A/B and their activating effects on platelet glycoprotein VI receptor to mediate collagen-induced platelet aggregation |
| Q33689745 | Targeting GPVI as a novel antithrombotic strategy |
| Q34917692 | The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke |
| Q28535276 | The GPVI-Fc fusion protein Revacept reduces thrombus formation and improves vascular dysfunction in atherosclerosis without any impact on bleeding times |
| Q30482557 | The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction |
| Q52550457 | The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion |
| Q51757699 | The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischemia in mice. |
| Q38106013 | The effects of arterial flow on platelet activation, thrombus growth, and stabilization. |
| Q38212058 | The functional role of platelets in the regulation of angiogenesis |
| Q38047358 | The future of glycoprotein VI as an antithrombotic target. |
| Q46790428 | The highly specific platelet glycoprotein (GP) VI agonist trowaglerix impaired collagen-induced platelet aggregation ex vivo through matrix metalloproteinase-dependent GPVI shedding. |
| Q46530171 | The immunoadhesin glycoprotein VI-Fc regulates arterial remodelling after mechanical injury in ApoE-/- mice |
| Q37798968 | The role of calpain in diabetes-associated platelet hyperactivation. |
| Q26801407 | The role of platelets in the recruitment of leukocytes during vascular disease |
| Q91530211 | Thrombo-inflammation in acute ischaemic stroke - implications for treatment |
| Q34316343 | Thrombosis as an intravascular effector of innate immunity |
| Q101476302 | Vascular protective effect of aspirin and rivaroxaban upon endothelial denudation of the mouse carotid artery |
| Q84912890 | [Acute ischemic stroke. New approaches to antithrombotic treatment] |
| Q83592968 | [Periinterventional antiplatelet therapy: from bench to bedside] |
Search more.